Last update 08 May 2025
Fina Biotech SL

Fina Biotech SL

Private Company|2002|Spain|
10-50
|
www.finabiotech.es

Overview

Related

1
Drugs associated with Fina Biotech SL
Skeletal muscle-derived autologous stem cell therapy (Fina Biotech)
Target-
Mechanism
Cell replacements
Active Org.-
Originator Org.
Fina Biotech SLFina Biotech SL
Active Indication-
Inactive Indication
Myocardial Infarction
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Fina Biotech SL
NCT00975234
/ TerminatedPhase 2IIT
Phase II, Randomised, Controlled Study of Treatment With Revascularisation Surgery With or Without Injection of Autologous Skeletal Myoblasts in Patients With Old Myocardial Infarction
100 Clinical Results associated with Fina Biotech SL
Login to view more data
0 Patents (Medical) associated with Fina Biotech SL
Login to view more data
100 Deals associated with Fina Biotech SL
Login to view more data
100 Translational Medicine associated with Fina Biotech SL
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 18 Jun 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Skeletal muscle-derived autologous stem cell therapy (Fina Biotech)
Myocardial Infarction
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free